| Product Name | Leishmania IgG/IgM rapid assay kit |
| Catalog No. | CA-00164 |
| Description | The leishmania IgG/IgM rapid assay kit is a rapid diagnostic tool for the detection of antibodies (IgG and IgM) to the leishmania virus. The kit quickly identifies the presence of specific antibodies against leishmania virus in the body, which is important for early screening and diagnosis. |
| Application | This product can be used for rapid in vitro screening of leishmania IgG/IgM. |
| Operating Temperature | Store at 4-30°C. |
| Transportation Condition | Transportation at room temperature. |
Leishmania IgG/IgM Rapid Assay Kit, also known as the Leishmania Antibody Rapid Test, is a crucial diagnostic tool for detecting antibodies against Leishmania donovani, the parasite responsible for visceral leishmaniasis, commonly referred to as Kala-Azar. This disease is a severe and potentially fatal form of leishmaniasis, transmitted to humans by the bites of infected Phlebotomus sandflies.
Visceral leishmaniasis is characterized by prolonged fever, weight loss, enlargement of the spleen and liver, and anemia. It is a significant public health concern in many parts of the world, particularly in tropical and subtropical regions. Early and accurate diagnosis is essential for effective treatment and management of the disease.
The Leishmania IgG/IgM Rapid Assay Kit is designed to detect both IgG and IgM antibodies in human serum, plasma, or whole blood. This dual detection capability allows for the identification of both recent and past infections, providing valuable information for clinical diagnosis and epidemiological studies.
·Rapid Results: Provides results within 10-15 minutes, enabling quick clinical decision-making.
·Simultaneous Detection: Detects both IgG and IgM antibodies in a single test, offering comprehensive screening.
·High Sensitivity and Specificity: Demonstrates high accuracy in detecting Leishmania antibodies, with sensitivity and specificity rates exceeding 99.9%.
·User-Friendly: Simple to use, requiring minimal training, making it suitable for both laboratory and point-of-care settings.
·Convenient Sampling: Utilizes whole blood, serum, or plasma, providing flexibility in sample collection.
·No Equipment Required: Can be performed without specialized laboratory equipment, enhancing its portability and accessibility.
·Time-Efficient: Reduces the time required for diagnosis, allowing for prompt treatment and management of infected individuals.
·Cost-Effective: Eliminates the need for expensive laboratory infrastructure and extensive training, making it accessible to a wide range of healthcare providers.
·Versatile Application: Suitable for use in clinics, hospitals, field settings, and large-scale screening efforts, supporting rapid response to outbreaks.
·Reduces Misdiagnosis: By accurately detecting specific antibodies, it helps in avoiding unnecessary treatments and targeted interventions.
·Supports Public Health: Facilitates large-scale screening and monitoring efforts, aiding in the control and prevention of leishmaniasis outbreaks.
For in vitro diagnostic use.
|
There is no product in your cart. |
Copyright © 2025 Alta DiagenoTech. All rights reserved.
